{"data":{"type":"company_profile_ai","id":131577,"entity_id":"wefunder:company:131577","attributes":{"canonical_url":"https://wefunder.com/grythealth","retrieval_urls":{"canonical":"https://wefunder.com/grythealth","json":"https://wefunder.com/grythealth.json","markdown":"https://wefunder.com/grythealth.md","ai_json":"https://wefunder.com/grythealth.ai.json","ai_text":"https://wefunder.com/grythealth.ai.txt","changelog_json":"https://wefunder.com/grythealth.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-04T05:02:54Z","generated_at":"2026-06-04T09:06:47Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":false,"privacy_mode":"unlisted","invite_only":false},"company":{"id":131577,"entity_id":"wefunder:company:131577","slug":"grythealth","name":"GRYT Health, Inc","tagline":"Increasing access to new cancer treatments","location":"Rochester, NY","website":"https://grythealth.com/","total_amount_raised":78632,"total_investors":26,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 78632","citation":"https://wefunder.com/grythealth#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-05T05:02:54Z"},{"claim_id":"claim-total-investors","text":"Total investors: 26","citation":"https://wefunder.com/grythealth#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-05T05:02:54Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 78632","citation":"https://wefunder.com/grythealth#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-05T05:02:54Z"},{"claim_id":"claim-total-investors","text":"Total investors: 26","citation":"https://wefunder.com/grythealth#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-05T05:02:54Z"}],"company_claims":{"tagline":"Increasing access to new cancer treatments","story":"Gryt Health (‘grit’) amplifies voices to improve health outcomes. Gryt is a healthtech company owned by survivors and caregivers. By always putting the patient experience first, we work to improve medicine development, access to equitable care and outcomes for all.\u0026nbsp;Visit grythealth.com to learn more.Through our innovative, patient engagement platform, Gryt provides clinical trial patient activation, patient experience research, and patient engagement services to the majority of the Top 10 global pharmaceutical companies. Additionally, we work with clinical research organizations, life sciences and biotech companies who are leading cutting edge new treatment development.View slides in a new windowSourceFuture projections are not guaranteedFuture projections are not guaranteedJoin the CommunityShare with your loved ones","quick_facts":["Over $12 million booked revenue from 20 pharmaceutical and biotech companies","Founded by cancer survivors and caregivers","Established patient community with 50 million interactions to date","$5 million in projected sales pipeline with 23 treatment development clients","$13.4 billion annual TAM across patient insights, clinical trial recruiting, \u0026amp; treatment marketing","New FDA requirements make Gryt's services critical","$5.5 million invested from 18 investors and 4 funds, including The Omidyar Group (founder of eBay)","Team of industry experts from pharma, Wall Street, tech, research, and patient advocacy"]},"computed_metrics":{"total_amount_raised":78632,"total_investors":26,"team_size":9,"featured_investor_count":5,"faq_count":2,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"Over $12 million booked revenue from 20 pharmaceutical and biotech companies","citation":"https://wefunder.com/grythealth#claim-fact-1","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-2","value":"Founded by cancer survivors and caregivers","citation":"https://wefunder.com/grythealth#claim-fact-2","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-3","value":"Established patient community with 50 million interactions to date","citation":"https://wefunder.com/grythealth#claim-fact-3","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-4","value":"$5 million in projected sales pipeline with 23 treatment development clients","citation":"https://wefunder.com/grythealth#claim-fact-4","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-5","value":"$13.4 billion annual TAM across patient insights, clinical trial recruiting, \u0026amp; treatment marketing","citation":"https://wefunder.com/grythealth#claim-fact-5","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-6","value":"New FDA requirements make Gryt's services critical","citation":"https://wefunder.com/grythealth#claim-fact-6","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-7","value":"$5.5 million invested from 18 investors and 4 funds, including The Omidyar Group (founder of eBay)","citation":"https://wefunder.com/grythealth#claim-fact-7","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"},{"claim_id":"claim-fact-8","value":"Team of industry experts from pharma, Wall Street, tech, research, and patient advocacy","citation":"https://wefunder.com/grythealth#claim-fact-8","observed_at":"2026-06-04T05:02:54Z","expires_at":"2026-06-11T05:02:54Z"}],"latest_fundraise":{"id":81222,"entity_id":"wefunder:fundraise:81222","state":"successful","offering_type":"4(a)(6)","structure":"equity","testing_the_waters":false,"can_invest_now":false,"funding_started_at":"2024-06-21T23:37:04Z","funding_closed_at":"2025-04-05T04:01:58Z"},"investor_memos":[],"team":[{"id":3416218,"entity_id":"wefunder:company_role:3416218","name":"David Craig","title":"Board Member \u0026 CEO","role":"founder","profile_url":"https://wefunder.com/david.craig.1"},{"id":3416219,"entity_id":"wefunder:company_role:3416219","name":"Shelley Nolden","title":"Board Chair \u0026 Angel Investor","role":"founder"},{"id":3416220,"entity_id":"wefunder:company_role:3416220","name":"Brad Love","title":"Board Member \u0026 Chief Culture Officer","role":"founder"},{"id":5041591,"entity_id":"wefunder:company_role:5041591","name":"Bill Walsh","title":"Chief Financial Officer","role":"employee","profile_url":"https://wefunder.com/bill.walsh"},{"id":3613726,"entity_id":"wefunder:company_role:3613726","name":"Uma Rana","title":"Chief of Strategic Partnerships","role":"employee"},{"id":3613724,"entity_id":"wefunder:company_role:3613724","name":"David Aleksandrowicz","title":"Chief Information Officer","role":"employee"},{"id":4276818,"entity_id":"wefunder:company_role:4276818","name":"Sheila Thorne","title":"Board Member","role":"employee"},{"id":4276823,"entity_id":"wefunder:company_role:4276823","name":"Guy Boike, MD","title":"Board Member","role":"employee"},{"id":4316727,"entity_id":"wefunder:company_role:4316727","name":"Gryt Staff","title":"Staff","role":"founder","profile_url":"https://wefunder.com/grytstaff"}],"featured_investors":[{"id":1271,"entity_id":"wefunder:company_investor_profile:1271","name":"The Omidyar Group","bio":"The Omidyar Group is a diverse collection of companies, organizations and initiatives, each guided by its own approach, but all united by a common desire to catalyze social impact.","profile_url":"https://wefunder.com/the.omidyar.group"},{"id":1272,"entity_id":"wefunder:company_investor_profile:1272","name":"Excell Partners","bio":"Excell is a VC fund that invests in high-tech high-growth startups in New York State focused on Upstate NY.","profile_url":"https://wefunder.com/excell.partners"},{"id":1273,"entity_id":"wefunder:company_investor_profile:1273","name":"Michigan Capital Network","bio":"MCN Ventures is a venture capital firm investing out of Fund III and Fund IV in early-stage companies in the life sciences, advanced manufacturing, and software \u0026amp; tech industry segments.","profile_url":"https://wefunder.com/michigan.capital.network"},{"id":1274,"entity_id":"wefunder:company_investor_profile:1274","name":"Tempo Group","bio":"Tempo Group is a non-profit outpatient facility that treats individuals suffering from addiction.","profile_url":"https://wefunder.com/tempo.group"},{"id":8793,"entity_id":"wefunder:company_investor_profile:8793","name":"Dave Romenesko","profile_url":"https://wefunder.com/dave.romenesko.1","endorsement_quote":"The Tempo SPE Group manages Angel investment into 10 startups, 4 of which are in health care. Gryt provides significant assistance for patients to find solutions to their cancer diagnosis. One of our startups is using Gryt to assist in a clinical trial. I am on the Board of that startup and I recommended Gryt. It is important for investors to complete their diligence before they invest in startups. Tempo has done so and continues to invest for Gryt provides an excellent service to patients, pharma and clinical trials for new life saving drugs. Better patient outcomes comes from better patient information. That information allows pharma to better design clinicals and get life saving results."}],"relationships":[{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:user:2846577","target_url":"https://wefunder.com/david.craig.1"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:3416219"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:3416220"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:user:3525928","target_url":"https://wefunder.com/bill.walsh"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:3613726"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:3613724"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:4276818"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:company_role:4276823"},{"source_entity_id":"wefunder:company:131577","relation":"has_team_member","target_entity_id":"wefunder:user:2840911","target_url":"https://wefunder.com/grytstaff"},{"source_entity_id":"wefunder:company:131577","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:6991","target_url":"https://wefunder.com/the.omidyar.group"},{"source_entity_id":"wefunder:company:131577","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:5309","target_url":"https://wefunder.com/excell.partners"},{"source_entity_id":"wefunder:company:131577","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:6992","target_url":"https://wefunder.com/michigan.capital.network"},{"source_entity_id":"wefunder:company:131577","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:6994","target_url":"https://wefunder.com/tempo.group"},{"source_entity_id":"wefunder:company:131577","relation":"has_featured_investor","target_entity_id":"wefunder:user:4548627","target_url":"https://wefunder.com/dave.romenesko.1"},{"source_entity_id":"wefunder:company:131577","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:81222"}],"faq":[{"question":"Can you share your thoughts on how often you will update us on how things are progressing with your goals and business plan? Secondly, do you intend to file the annual report with the SEC? Thanks for your feedback.","answer":"Hello Eric. Thanks for your questions. Yes, we file the annual SEC requirement. We do a detailed quarterly update, as well as share significant achievements and goals as they happen. We value your engagement."},{"question":"So is the revenue model, \"finder fees\" paid by bio/pharmaceutical companies for finding patients to participate in research studies?","answer":"Hi LD. Thanks for your question. The answer is no to that. As a team of survivors and caregivers ourselves, we have two service lines. \"Empowerment programs\" are where we invite patients to share their experience and perspective for other patients and healthcare providers to learn from. We co-create these programs with the people living the experience and have developed 250 to-date. \"Research programs\" are where our team develops the methodology \u0026amp; questions with the client, invites patien..."}],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-04T09:06:47Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T05:02:54Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-05-29T14:35:33Z","as_of":"2026-06-04T09:06:47Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-05-29T14:35:33Z","as_of":"2026-06-04T09:06:47Z","confidence":"medium"}}}}}}